Europe — EMA
Morphine Hcl Sterop (Morphine Hydrochloride)
GNH USA supplies Morphine Hcl Sterop (Morphine), an opioid analgesic for acute, cancer and postoperative pain. Request a quote for global supply today.
Request sourcing
What is Morphine Hydrochloride?
Morphine, the active ingredient in Morphine Hcl Sterop, is a opioid analgesic presented as a sterile injectable solution for epidural, intramuscular, intrathecal use. It treats severe acute pain, chronic cancer pain and postoperative pain in adult patients. GNH USA supplies Morphine Hcl Sterop as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Morphine Hydrochloride used for?
Morphine, an opioid analgesic, is used for severe pain management across several clinical settings.
Severe acute pain: provides rapid analgesia for trauma or postoperative patients. Chronic cancer pain: helps control persistent pain in oncology patients. Postoperative pain: reduces pain after surgical procedures.
What are the side effects of Morphine Hydrochloride?
Common Side Effects: - Nausea - Constipation - Drowsiness - Dizziness - Sweating - Itching (pruritus)
Serious or Rare Side Effects: - Respiratory depression - Severe hypotension - Profound sedation leading to coma - Anaphylactic reactions - Opioid dependence or abuse
What precautions apply to Morphine Hydrochloride?
Morphine Hcl Sterop requires careful clinical monitoring due to its potency and potential for adverse reactions.
Assess respiratory function: monitor breathing rate and oxygen saturation. Evaluate renal and hepatic function: adjust dosing if impairment is present. Avoid in severe asthma: risk of bronchospasm. Use caution with CNS depressants: increased sedation and respiratory risk. Monitor for dependence/abuse: assess patient history regularly. Store at ambient temperature: keep in original packaging, protect from moisture and light.
What does Morphine Hydrochloride interact with?
Morphine may interact with several drug classes, altering its safety profile.
Major Interactions (Avoid): - Concurrent opioids: heightened risk of respiratory depression. - MAO inhibitors: potential for serotonin syndrome. - CNS depressants (benzodiazepines, barbiturates): additive sedation. - Strong CYP3A4 inhibitors (ketoconazole, erythromycin): increased plasma concentrations. - Alcohol: enhanced central nervous system depression.
Moderate Interactions (Monitor Closely): - CYP3A4 inducers (rifampin, carbamazepine): reduced analgesic effect. - Diuretics: may exacerbate hypotension. - Anticholinergics: can worsen opioid‑induced constipation.



